Multi-targeted therapy resistance via drug-induced secretome fucosylation
Cancer secretome is a reservoir for aberrant glycosylation.How therapies alter this post- translational cancer hallmark and the consequences thereof remain elusive.Here, we show that an elevated secretome fucosylation is a pan-cancer signature of Protective Underwear both response and resistance to multiple targeted therapies.Large-scale pharmacoge